Quantcast

Latest Multiple myeloma Stories

2014-12-06 16:21:17

- Note: This press release corresponds to abstract 31. SAN FRANCISCO, Dec. 6, 2014 /PRNewswire/ -- New IMBRUVICA(®) (ibrutinib) Phase II data announced here today by Pharmacyclics, Inc.

2014-12-06 12:21:27

Data From Pivotal Trial Published in the New England Journal of Medicine and Presented at the 56th American Society of Hematology (ASH) Annual Meeting and Exposition THOUSAND OAKS, Calif.

2014-12-04 12:24:15

Study shows the use of Internet-based tools can guide decision making in the treatment of multiple myeloma RESTON, Va., Dec.

2014-11-17 08:31:41

Data from 13 accepted abstracts include: NORTH CHICAGO, Ill., Nov.

2014-11-06 16:33:34

Presentations Including Pivotal Data on Kyprolis® and Blinatumomab, a BiTE® Immunotherapy, Demonstrate Company's Continued Commitment to Developing Treatments for Difficult-to-Treat Blood Cancers THOUSAND

2014-11-06 12:29:21

- Note: This release corresponds to ASH abstracts 22, 31, 78, 84, 176, 327, 505, 2096, 2312, 3448, 3474, 4454, 4469, 4680 RARITAN, N.J., Nov.

2014-10-28 08:36:53

MOSCOW, October 28, 2014 /PRNewswire/ -- Osteros Biomedica Ltd., a joint venture company of Maxwell Biotech Group and MBC Pharma Inc., and formed with the participation

2014-09-01 04:20:02

A*STAR scientists find new targets for modulating antibody response Singapore, Sept 1, 2014 - (ACN Newswire) - Scientists from A*STAR's


Word of the Day
immane
  • Monstrous in size or character; huge; prodigious; monstrously perverse, savage, cruel, etc.
The word 'immane' comes from the Latin word 'immanis', 'enormous'.
Related